Effect of A(2A) adenosine receptor stimulation and antagonism on synaptic depression induced by in vitro ischaemia in rat hippocampal slices

British Journal of Pharmacology

Volumn 128, Issue 5, 1999, Pages 1035-1044

  Latini, Serena ^a   Bordoni, Francesca ^a   Corradetti, Renato ^a   Pepeu, Giancarlo ^a   Pedata, Felicita ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

A(2A) and A1 adenosine receptors; Adenosine; CGS 21680; Hippocampal slices; In vitro ischaemia; SCH 58261; Synaptic responses; ZM 241385

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE A2A RECEPTOR; 1,3-DIPROPYL-8-CYCLOPENTYLXANTHINE; ADENOSINE RECEPTOR; DRUG DERIVATIVE; PHENETHYLAMINE DERIVATIVE; PYRIMIDINE DERIVATIVE; TRIAZINE DERIVATIVE; TRIAZOLE DERIVATIVE; XANTHINE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN SLICE; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPTIC TRANSMISSION; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; EXCITATORY POSTSYNAPTIC POTENTIAL; IN VITRO STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; SYNAPSE; VASCULARIZATION; WISTAR RAT;

ADENOSINE; ANIMALS; EXCITATORY POSTSYNAPTIC POTENTIALS; HIPPOCAMPUS; HYPOXIA-ISCHEMIA, BRAIN; MALE; PHENETHYLAMINES; PYRIMIDINES; RATS; RATS, WISTAR; RECEPTOR, ADENOSINE A2A; RECEPTORS, PURINERGIC P1; SYNAPSES; SYNAPTIC TRANSMISSION; TRIAZINES; TRIAZOLES; XANTHINES;

EID: 0032585939     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702888     Document Type: Article

References (60)

1. BONA, E., ADEN, U., GILLAND, E., FREDHOLM, B.B. & HAGBERG, H. (1997). Neonatal cerebral hypoxia-ischemia: the effect of adenosine receptor antagonists. Neuropharmacology, 36, 1327-1338.
2. CANHAO, P., DE MENDONÇA, A. & RIBEIRO, J.A. (1994). 1,3-Dipropyl-8-cyclopentylxanthine attenuates the NMDA response to hypoxia in the rat hippocampus. Brain Res., 661, 265-273.
3. CORRADETTI, R., LO CONTE, G., MORONI, F., PASSANI, M.B. & PEPEU, G. (1984). Adenosine decreases aspartate and glutamute release from rat hippocampal slices. Eur. J. Pharmacol., 104, 19-26.
4. CORRADETTI, R., MONETI, G., MORONI, F., PEPEU, G. & WIERASZKO, A. (1983). Electrical stimulation of the stratum radiatum increases the release and neosynthesis of aspartate, glutamate, and γ-aminobutyric acid in rat hippocampal slices. J. Neurochem., 41, 1518-1525.
5. 2A adenosine receptor agonists CGS21680 and HENECA in the rat hippocampus. Br. J. Pharmacol., 122, 1279-1284.
6. 2A receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 353, 261-271.
7. 2a receptors stimulate acetylcholine release from nerve terminals of the rat hippocampus. Neurosci. Lett., 196, 41-44.
8. 2a receptors in the rat hippocampus. Brain Res., 649, 208-216.
9. DIXON, A.K., GUBITZ, A.K., SIRINATHSINGHJI, D.J.S., RICHARDSON, P.J. & FREEMAN, T.C. (1996). Tissue distribution of adenosine receptor mRNAs in the rat. Br. J. Pharmacol., 118, 1461-1468.
10. 2A receptor in the rat striatum. J. Neurochem., 69, 315-321.
11. DUNWIDDIE, T.V. & DIAO, L. (1994). Extracellular adenosine concentrations in hippocampal brain slices and the tonic inhibitory modulation of evoked excitatory responses. J. Pharmacol. Exp. Ther., 268, 537-545.
12. 1 receptor-mediated responses in rat hippocampus. J. Neurosci., 17, 607-614.
13. 1 receptors and 5′-nucleotidase in the brain of some commonly used experimental animals. Neuroscience, 22, 813-826.
14. 2 dopamine receptors in the rat striatum. Molec. Brain Res., 14, 186-195
15. FOWLER, J.C. (1989). Adenosine antagonists delay hypoxia-induced depression of neuronal activity in hipoocampal brain slice. Brain Res., 490, 378-384.
16. FOWLER, J.C. (1990). Adenosine antagonists alter the synaptic response to in vitro ischemia in the rat hippocampus. Brain Res., 509, 331-334.
17. FREDHOLM, B.B., ABBRACCHIO, M.P., BURNSTOCK, G., DALY, J.W., HARDEN, T.K., JACOBSON, K.A., LEFF, P. & WILLIAMS, M. (1994). Nomenclature and classification of purinoceptors. Pharmacol. Rev., 46, 143-156.
18. FREDHOLM, B.B., DUNWIDDIE, T.D., BERGMAN, B. & LINDSTRÖM, K. (1984). Levels of adenosine and adenine nucleotides in slices of rat hippocampus. Brain Res., 295, 127-136.
19. 2 receptor antagonist, reduces cerebral ischemia injury in the mongolian gerbil. Life Sci., 55, PL 61-65.
20. GRIBKOFF, V.K., BAUMAN, L.A. & VANDERMAELEN, C.P. (1990). The adenosine antagonist 8-cyclopentyltheophilline reduces the depression of hippocampal neuronal responses during hypoxia. Brain Res., 512, 353-357.
21. 2 selective adenosine receptor agonist with preferential hypotensive activity. J. Pharmacol. Exp. Ther., 251, 47-55.
22. JAMES, S., XUEREB, J.H., ASKALAN, R. & RICHARDSON, P.J. (1992). Adenosine receptors in post-mortem human brain. Br. J. Pharmacol., 105, 238-244.
23. 2 receptors in rat brain. J. Pharmacol. Exp. Ther., 251, 888-893.
24. 3H]CGS 21680. Eur. J. Pharmacol., 168, 243-246.
25. 3H]CGS 21680 to rat brain using autoradiography. Neuropharmacology, 34, 393-403.
26. 3H]CGS 21680 to rat cortex differs from its binding to rat striatum. Eur. J. Pharmacol., 247, 103-110.
27. 2A receptor antagonist. Brain Res., 800, 328-335.
28. 2A receptor agonists and antagonists. Neuroscience, 85, 229-237.
29. KENAKIN, T. (1993). Stimulus-response mechanisms. In: Kenakin, T. (ed.) Pharmacologic analysis of drug-receptor interaction. Raven Press: New York, 39-68
30. KENAKIN, T. (1997). Drug response systems. In: Kenakin, T. (ed.) Pharmacologic analysis of drug-receptor interaction. Lippencott-Raven: Philadelphia, 106-144
31. 2A adenosine receptor agonist CGS 21680 reduces the synaptic depression induced by in vitro ischemia in rat hippocampal slices. Drug Dev. Res., 43, 213.
32. LATINI, S., BORDONI, F., CORRADETTI, R., PEPEU, G. & PEDATA, F. (1998b). Temporal correlation between adenosine outflow and synaptic potential inhibition in rat hippocampal slices during ischemia-like conditions. Brain Res., 794, 325-328.
33. LATINI, S., BORDONI, F., PEDATA, F. & CORRADETTI, R. (1999). Extracellular adenosine concentrations during in vitro ischaemia in rat hippocampal slices. Br. J. Pharmacol., 127, 729-739.
34. LATINI, S., CORSI, C., PEDATA, F. & PEPEU, G. (1995). The source of brain adenosine outflow during ischemia and electrical stimulation. Neurochem. Int., 27, 239-244.
35. 2 adenosine receptors: their presence and neuromodulatory role in the central nervous system. Gen. Pharmacol., 27, 925-933.
36. 2 receptor mediation of pre-and postsynaptic excitatory effects of adenosine in rat hippocampus in vitro. Eur. J. Pharmacol., 347, 173-182.
37. 3H]-CGS 21680 in the rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol., 354, 539-541.
38. LLOYD, H.G.E., LINDSTRÖM, K. & FREDHOLM, B.B. (1993). Intracellular formation and release of adenosine from rat hippocampal slices evoked by electrical stimulation or energy depletion. Neurochem. Int., 23, 173-185.
39. A-mediated actions during hypoxia in the rat hippocampus. Brain Res., 732, 261-266.
40. 2 receptors: selective localization in the human basal ganglia and alterations with disease. Neuroscience, 42, 697-706.
41. 2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats. NeuroReport, 9, 3955-3959.
42. 2 receptor-mediated responses in the rat hippocampus in vitro. Eur. J. Pharmacol., 362, 17-25.
43. 2A adenosine receptors: an apparent paradox. Drug Dev. Res., 45, 387-393.
44. 2 adenosine receptor agonist CGS 21680 enhances excitatory transmitter amino acid release from the ischemic rat cerebral cortex. Neurosci. Lett., 138, 169-172.
45. PEDATA, F., LATINI, S., PUGLIESE, A.M. & PEPEU, G. (1993). Investigations into the adenosine outflow from hippocampal slices evoked by ischemic-like conditions. J. Neurochem., 61, 284-289.
46. 2 adenosine receptor antagonists on cerebral ischemic injury in the gerbil. Brain Res., 705, 79-84.
47. 2A receptor stimulation enhances striatal extracellular glutamate levels in rats. Eur. J. Pharmacol. 287, 215-217.
48. 2a selective adenosine receptor antagonist. Br. J. Pharmacol., 115, 1096-1102.
49. 2A receptors in the rat central nervous system. J. Comp. Neurol., 401, 163-186.
50. RUDOLPHI, K.A., SCHUBERT, P., PARKINSON, F.E. & FREDHOLM, B.B. (1992). Neuroprotective role of adenosine in cerebral ischemia. TiPS, 13, 439-445.
51. 1 dopamine receptor. Brain Res., 519, 333-337.
52. 2 receptor mRNA in the human brain. Neurosci. Lett., 130, 177-181.
53. 2 adenosine receptors in the rat hippocampus. Neurosci. Lett., 138, 41-44.
54. 2 receptor-mediated excitatory actions on the nervous system. Progr. Neurobiol., 48, 167-189.
55. 2A receptor agonist and antagonist. Eur. J. Pharmacol., 287, 295-302.
56. VON LUBITZ, D.K.E.J. (1999). Adenosine and cerebral ischemia: therapeutic future or death of a brave concept? Eur. J. Pharmacol., 365, 9-25.
57. 3H]CGS 21680 to human and rat brain: evidence for multiple affinity sites. J. Neurochem., 55, 1763-1771.
58. 2 receptors in the rat brain. FASEB J., 3, A1047.
59. WU, L.G. & SAGGAU, P. (1994). Adenosine inhibits evoked synaptic transmission primarily by reducing presynaptic calcium influx in area CA1 of hippocampus. Neuron, 12, 1139-1148.
60. 2a adenosine receptor antagonist. J. Pharmacol. Exp. Ther., 276, 398-404.